The GLP-1 and dual GIP/GLP-1 RAs available in the UK include dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide
Additionally, studies in patients with T2DM are now needed to explore potential clinical benefits [197]
Please check the ingredient list on the product packaging for the most up-to-date information and to ensure it is suitable for your personal use
This move comes as June saw 3,763 active lawsuits in the GLP-1 MDL
The NTS is the main source of endogenous GLP-1 within the brain (Holt et al., 2019)
For example, one extensive review of semaglutides safety discusses the incidence of pancreatitis in study participants, as well as the potential link between GLP-1 RAs and pancreatic cancer.16 Its a sensible thing to study considering these drugs effect on the pancreas, and cases of pancreatitis were present in several studies, but researchers note that the incidence isnt meaningfully higher than that of the general population outside the study group